MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED)

PHASE2CompletedINTERVENTIONAL
Enrollment

766

Participants

Timeline

Start Date

July 31, 2003

Primary Completion Date

October 31, 2003

Study Completion Date

October 31, 2003

Conditions
Seasonal Allergies
Interventions
DRUG

MK0524

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00533208 - MK0524 Seasonal Allergic Rhinitis Study (0524-005)(COMPLETED) | Biotech Hunter | Biotech Hunter